featured
Effects of Intensive Glycemic Control on Microvascular Outcomes in Type 2 Diabetes Are Modified by Long-Term HbA1c Variability
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Research and Clinical Practice
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of intensive glycemic control on microvascular outcomes in type 2 diabetes mellitus are modified by long-term HbA1c variability: A post hoc analysis of the ACCORD trial
Diabetes Res. Clin. Pract. 2024 Jan 19;[EPub Ahead of Print], JM Wang, MY Miao, YP Jia, XW Wang, XB Wu, ZX Wan, Y Zheng, LQ Qin, FR Li, GC ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.